Future studies should investigate GLYAT’s metabolic functions, epigenetic regulation, role in the tumor microenvironment, and impact on disease progression and patient survival to elucidate its precise role in KIRC tumorigenesis and progression. The gene discussed is GLYAT; the disease is neoplasm.